Similar articles for PMID: 33509919

Year	Number of Results
1997	2
1998	4
2001	4
2003	1
2004	4
2005	4
2006	4
2007	8
2008	2
2009	1
2010	2
2011	7
2012	6
2013	4
2014	3
2015	5
2016	12
2017	10
2018	10
2019	7
2020	12
2021	10
2022	8
2023	7
2024	0

1

Determining the Degree of Dopaminergic Denervation Based on the Loss of Nigral Hyperintensity on SMWI in Parkinsonism.

Bae YJ, Song YS, Kim JM, Choi BS, Nam Y, Choi JH, Lee WW, Kim JH. Bae YJ, et al. AJNR Am J Neuroradiol. 2021 Apr;42(4):681-687. doi: 10.3174/ajnr.A6960. Epub 2021 Jan 28. AJNR Am J Neuroradiol. 2021. PMID: 33509919 Free PMC article.

2

Comparison of susceptibility-weighted imaging and susceptibility map-weighted imaging for the diagnosis of Parkinsonism with nigral hyperintensity.

Bae YJ, Song YS, Choi BS, Kim JM, Nam Y, Kim JH. Bae YJ, et al. Eur J Radiol. 2021 Jan;134:109398. doi: 10.1016/j.ejrad.2020.109398. Epub 2020 Nov 11. Eur J Radiol. 2021. PMID: 33264728

3

Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.

Bae YJ, Kim JM, Kim E, Lee KM, Kang SY, Park HS, Kim KJ, Kim YE, Oh ES, Yun JY, Kim JS, Jeong HJ, Jeon B, Kim SE. Bae YJ, et al. Mov Disord. 2016 May;31(5):684-92. doi: 10.1002/mds.26584. Epub 2016 Mar 17. Mov Disord. 2016. PMID: 26990970 Review.

4

Initial diagnostic workup of parkinsonism: Dopamine transporter positron emission tomography versus susceptibility map-weighted imaging at 3T.

Sung YH, Lee J, Nam Y, Shin HG, Noh Y, Hwang KH, Lee H, Kim EY. Sung YH, et al. Parkinsonism Relat Disord. 2019 May;62:171-178. doi: 10.1016/j.parkreldis.2018.12.019. Epub 2018 Dec 18. Parkinsonism Relat Disord. 2019. PMID: 30580909

5

Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.

Iranzo A, Valldeoriola F, Lomeña F, Molinuevo JL, Serradell M, Salamero M, Cot A, Ros D, Pavía J, Santamaria J, Tolosa E. Iranzo A, et al. Lancet Neurol. 2011 Sep;10(9):797-805. doi: 10.1016/S1474-4422(11)70152-1. Epub 2011 Jul 28. Lancet Neurol. 2011. PMID: 21802993

6

A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism.

Sung YH, Kim JS, Yoo SW, Shin NY, Nam Y, Ahn TB, Yoo D, Lee KM, Kim HG, Koh SB, Kim J, Kim I, Kwon DY, Lee Y, Kim C, Chung SJ, Jo S, Lee SH, Kim SJ, Kim M, Lyoo CH, Baek MS, Kang SY, Chang SK, Jo SW, Lee SA, Ma HI, Kim YE, Kim ES, Kim YJ, Kim HS, Woo MH, Choi HJ, Kim EY. Sung YH, et al. Eur Radiol. 2022 May;32(5):3597-3608. doi: 10.1007/s00330-021-08454-z. Epub 2022 Jan 22. Eur Radiol. 2022. PMID: 35064313

7

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

Iranzo A, Lomeña F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pavía J, Gallego J, Seppi K, Högl B, Tolosa E, Poewe W, Santamaria J; Sleep Innsbruck Barcelona (SINBAR) group. Iranzo A, et al. Lancet Neurol. 2010 Nov;9(11):1070-7. doi: 10.1016/S1474-4422(10)70216-7. Epub 2010 Sep 16. Lancet Neurol. 2010. PMID: 20846908

8

Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease.

Kim HK, Kim T, Baek MS, Kim EY, Sung YH, Lee JH, Ryu YH, Ahn SJ, Yoo HS, Lyoo CH. Kim HK, et al. Eur J Neurol. 2023 Jun;30(6):1639-1647. doi: 10.1111/ene.15781. Epub 2023 Mar 26. Eur J Neurol. 2023. PMID: 36915220

9

Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.

Appel L, Jonasson M, Danfors T, Nyholm D, Askmark H, Lubberink M, Sörensen J. Appel L, et al. J Nucl Med. 2015 Feb;56(2):234-42. doi: 10.2967/jnumed.114.148619. Epub 2015 Jan 15. J Nucl Med. 2015. PMID: 25593112 Free article.

10

123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.

Lorberboym M, Djaldetti R, Melamed E, Sadeh M, Lampl Y. Lorberboym M, et al. J Nucl Med. 2004 Oct;45(10):1688-93. J Nucl Med. 2004. PMID: 15471834 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year